Investing
Top Analyst Downgrades and Stocks to Sell: CVS, DaVita, Zillow and More
Published:
Last Updated:
Investors frequently get to see the analyst upgrades and Buy ratings from Wall Street firms. What investors often do not get to see is when analyst downgrade stocks to sell or to avoid. 24/7 Wall St. reviews many fresh research calls each and every day to find great ideas from value stocks to growth stocks to dividend stocks, and we have broken out the negative analyst calls. These are this Wednesday’s top analyst downgrades and cautious research notes from Wall Street.
CVS Caremark Corp. (NYSE: CVS) was downgraded to Hold from Buy at Cantor Fitzgerald.
DaVita Healthcare Partners Inc. (NYSE: DVA) was downgraded to Sector Perform from Outperform at RBC Capital Markets.
Endeavour International Corp. (NYSE: END) was downgraded to Hold from Buy at Canaccord Genuity.
Endo Health Solutions Inc. (NASDAQ: ENDP) was downgraded to Sell from an already cautious Neutral rating at Janney.
Five Oaks Investment Corp. (NYSE: OAKS) was downgraded to Neutral from Outperform at Credit Suisse.
Marathon Oil Corp. (NYSE: MRO) was downgraded to Neutral from Buy at BofA/Merrill Lynch.
Zillow Inc. (NASDAQ: Z) was downgraded to Sector Perform from Outperform at RBC Capital Markets.
Let’s face it: If your money is just sitting in a checking account, you’re losing value every single day. With most checking accounts offering little to no interest, the cash you worked so hard to save is gradually being eroded by inflation.
However, by moving that money into a high-yield savings account, you can put your cash to work, growing steadily with little to no effort on your part. In just a few clicks, you can set up a high-yield savings account and start earning interest immediately.
There are plenty of reputable banks and online platforms that offer competitive rates, and many of them come with zero fees and no minimum balance requirements. Click here to see if you’re earning the best possible rate on your money!
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.